Westchester Capital Management (New York)’s Psyence Biomedical Warrant PBMWW Stock Holding History

Westchester Capital Management (New York)’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92,073	Closed	-$2.3K	–	316
2025 Q3	$2.3K	Hold	92,073	–	–	﹤0.01%	256
2025 Q2	$1.86K	Hold	92,073	–	–	﹤0.01%	209
2025 Q1	$1.56K	Hold	92,073	–	–	﹤0.01%	170
2024 Q4	$1.13K	Hold	92,073	–	–	﹤0.01%	164
2024 Q3	$1.17K	Hold	92,073	–	–	﹤0.01%	186
2024 Q2	$976	Hold	92,073	–	–	﹤0.01%	222
2024 Q1	$6.59K	Buy	+92,073	New	+$5.74K	﹤0.01%	225

Other funds holding PBMWW

Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return